G. Arnold

Brief Report: Pharmacodynamics, Safety, and Clinical Efficacy of AMG 811, a Human Anti–Interferon‐γ Antibody, in Patients With Discoid Lupus Erythematosus

M. Boedigheimer, David A. Martin, M. Damore, 2017, Arthritis & rheumatology.

Blockade of Interferon‐γ Normalizes Interferon‐Regulated Gene Expression and Serum CXCL10 Levels in Patients With Systemic Lupus Erythematosus

M. Boedigheimer, J. Buyon, M. Damore, 2015, Arthritis & rheumatology.

Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells

S. Powers, K. Nguyen, S. Elliott, 2008, British Journal of Cancer.

Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus

M. Boedigheimer, J. Ferbas, B. Sullivan, 2016, Lupus Science & Medicine.

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis

Z. Amoura, J. Merrill, F. Hiepe, 2018 .

Reduced TRPM8 expression underpins reduced migraine risk and attenuated cold pain sensation in humans

M. Backonja, N. Gavva, G. E. Arnold, 2019, Scientific Reports.

Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-γ monoclonal antibody, in SLE subjects without or with lupus nephritis

J. Sánchez-Guerrero, M. Boedigheimer, M. Damore, 2017, Lupus Science & Medicine.

Pharmacokinetic comparison of a diverse panel of non-targeting human antibodies as matched IgG1 and IgG2 isotypes in rodents and non-human primates

K. Walker, F. Jacobsen, Qing Chen, 2019, PloS one.